Pentomone (
INNTooltip International Nonproprietary Name,
USANTooltip United States Adopted Name) (developmental code name Lilly 113935 or LY-113935) is a
nonsteroidal antiandrogen (NSAA) described as a "
prostate growth inhibitor" which was never marketed.[1] It was synthesized and assayed in 1978.[1]